Skip to main content

Table 1 Characteristics of all patients and patients with ≥2 drugs

From: Potential drug-drug interactions in patients with indication for prophylactic implantation of a cardioverter defibrillator: a cross-sectional analysis

 

All patients

(n = 524)

Patients with ≥ 2 drugs

(n = 383)

n (%) / Mean ± SD

n (%) / Mean ± SD

Age (in years)

64.4

12.6

64.3

12.5

Sex

Male

411

(78.4)

304

(79.4)

Female

113

(21.6)

79

(20.6)

Place of residence

Germany

453

(86.5)

348

(90.9)

Switzerland

71

(13.5)

35

(9.1)

Race

White

501

(95.6)

369

(96.3)

Black

4

(0.8)

3

(0.8)

Asian

6

(1.1)

4

(1.0)

Unknown

13

(2.5)

7

(1.8)

Number of comorbidities

0

108

(20.6)

81

(21.1)

1

194

(37.0)

143

(37.3)

2

143

(27.3)

101

(26.4)

3

66

(12.6)

46

(12.0)

4

11

(2.1)

10

(2.6)

5

2

(0.4)

2

(0.5)

Most frequent comorbidities

Hypertension

359

(68.5)

260

(67.9)

Diabetes

156

(29.8)

121

(31.6)

Stroke/TIA

59

(11.3)

44

(11.5)

COPD

53

(10.1)

39

(10.2)

Peripheral arterial disease

45

(8.6)

28

(7.3)

Number of taken drugs

 

3.6

2.6

4.7

2.2

  1. SD Standard deviation, TIA Transient ischaemic attack, COPD Chronic obstructive pulmonary disease